ACTIVE

BioLizard

Financial year 2025 · Closed on 31/12/2025

Net result324,2 k €+42,8 %over 1 year
Gross margin3,9 M €+3,8 %over 1 year
Equity3,7 M €+23,1 %over 1 year
Workforce34,2 ETP+3,3 %over 1 year

Identity

Source · BCE/KBO

BioLizard is a Public limited company incorporated in 2018. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Gent. It employs on average 34,2 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0713.914.951
Incorporation
26/11/2018
Legal form
Public limited company
Registered office
Foreestelaan 88 box 201
9000 Gent · FlandreSee on map
Contributed capital
466 664,00 €
Latest accounts
31/12/2025
Average workforce
34,2 ETP
Joint committees (1)
  • 200
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 8 filings

Trend over 7 financial years

20252024202320222021
Income statement
Gross margin3,9 M €3,8 M €3,8 M €2,7 M €1,2 M €
EBITDA375,7 k €417,9 k €736,8 k €828,2 k €479 k €
Operating result129,1 k €240,3 k €611,3 k €656,9 k €369,2 k €
Net result324,2 k €227,1 k €481,3 k €597,4 k €429,5 k €
Balance sheet
Equity3,7 M €3 M €2,5 M €2 M €908,3 k €
Total assets5,3 M €4,3 M €3,4 M €3,1 M €1,5 M €
Cash827,4 k €681,9 k €711,8 k €948,4 k €444,1 k €
Debts1,1 M €963,2 k €715,2 k €793,7 k €613,3 k €
Other
Workforce34,2 ETP33,1 ETP29,4 ETP21,2 ETP10,6 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 2,5 M€ and 5 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

3 active · 3 ended

Active mandates

DirectorMandates in this companyPeriodOther mandatescurrentendedstruck offbankruptcies
Effra Consult BO1014.983.650Represented by Caroline Vanovermeire
Directorsince 16/08/2024
NOVALIS GENERAL PARTNERS Ltd.0704.989.961Represented by Jan VAN DEN BERGHE
Managing directorsince 26/11/2019Director26/11/2019 → 2024 accountsended
Ceelen Consultancy0536.273.210Represented by Liesbeth Ceelen
Persoon belast met dagelijks bestuur

Ended mandates

DirectorMandates in this companyPeriodOther mandatescurrentendedstruck offbankruptcies
NOVALIS GENERAL PARTNERS LTDRepresented by Jan VAN DEN BERGHE
Managing director26/11/2019 → 2019 accounts
NOROMID0721.787.688Represented by Gerben MENSCHAERT
Director10/04/2019 → 16/08/2024
BioLizard0713.914.951Represented by Liesbeth Ceelen
Persoon belast met dagelijks bestuur2022 accounts

Other companies at this address

Foreestelaan 88 9000 Gent
CompanyCBE no.
0781.744.675
0740.649.339
0783.606.580
0802.243.151
PIA Advisory● Active
1010.256.780
PIA Go!● Active
0476.297.813
PIA GROEP● Active
0668.662.372
PIA Group● Active
1030.270.553
PIA Group BeLux● Active
0718.884.618
0790.995.210
0794.819.384
1032.181.552
1032.308.048
ROBOVISION● Active
0899.613.236
1038.558.907
0453.673.651

Full financial information

Source · NBB
202520242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date03/07/202602/07/202522/07/202404/07/202327/06/202227/06/2022
General meeting26/06/202627/06/202528/06/202430/06/202324/06/202203/06/2022
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 8 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202526/06/202603/07/2026DutchPDF
Abridged model31/12/202427/06/202502/07/2025DutchPDF
Abridged model31/12/202328/06/202422/07/2024DutchPDF
Abridged model31/12/202230/06/202304/07/2023DutchPDF
Abridged model31/12/202124/06/202227/06/2022DutchPDF
Abridged modelCorrection31/12/202003/06/202227/06/2022DutchPDF
Abridged model31/12/202025/06/202123/07/2021DutchPDF
Abridged model31/12/201917/04/202008/07/2020DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 2,5 M€ and 5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

3 active · 3 ended

Active mandates

DirectorMandates in this companyPeriodOther mandatescurrentendedstruck offbankruptcies
Effra Consult BO1014.983.650Represented by Caroline Vanovermeire
Directorsince 16/08/2024
NOVALIS GENERAL PARTNERS Ltd.0704.989.961Represented by Jan VAN DEN BERGHE
Managing directorsince 26/11/2019Director26/11/2019 → 2024 accountsended
Ceelen Consultancy0536.273.210Represented by Liesbeth Ceelen
Persoon belast met dagelijks bestuur

Ended mandates

DirectorMandates in this companyPeriodOther mandatescurrentendedstruck offbankruptcies
NOVALIS GENERAL PARTNERS LTDRepresented by Jan VAN DEN BERGHE
Managing director26/11/2019 → 2019 accounts
NOROMID0721.787.688Represented by Gerben MENSCHAERT
Director10/04/2019 → 16/08/2024
BioLizard0713.914.951Represented by Liesbeth Ceelen
Persoon belast met dagelijks bestuur2022 accounts

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Registered office01/04/2026
    MAATSCHAPPELIJKE ZETEL
    PDF
  • Mandates22/10/2024
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates05/01/2023
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Capital / shares02/07/2021
    KAPITAAL - AANDELEN
    PDF
  • Capital / shares09/09/2020
    KAPITAAL - AANDELEN
    PDF
  • Mandates21/06/2019
    MAATSCHAPPELIJKE ZETEL - ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates23/01/2019
    ONTSLAGEN - BENOEMINGEN - DIVERSEN
    PDF
  • Other28/11/2018
    RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts
Year
Identity
Incorporation
Name
Registered office
Annual accounts
Filings7 filings
Mandates
NOVALIS GENERAL PARTNERS Ltd.
Ceelen Consultancy
Effra Consult BV BVBA
NOVALIS GENERAL PARTNERS LTD
NOROMID
BioLizard
201820192020202120222023202420252026
BioLizard
Foreestelaan 88 bte 201, 9000 GentOttergemsesteenweg - Zuid 808 bte B511, 9000 Gent
Managing directorDirector
Persoon belast met dagelijks bestuur
Director
Director
CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE
Registered addressPeriodSource
Foreestelaan 88 bte 201, 9000 GentCurrent
accounts 2025
Accounts 2025 · 2026-00275177
Ottergemsesteenweg - Zuid 808 bte B511, 9000 Gent
accounts 2020 → 2024
Accounts 2024 · 2025-00250328

Company names

Source · NBB annual accounts, CBE
NamePeriodSource
BioLizardCurrent
accounts 2019 → 2025
Accounts 2025 · 2026-00275177

Events

  1. 2025
    Annual accounts 2025324,2 k €↑
  2. 2024
    Annual accounts 2024227,1 k €↓
  3. 2023
    Annual accounts 2023481,3 k €↓
  4. 2022
    Annual accounts 2022597,4 k €↑
  5. 2021
    Annual accounts 2021429,5 k €↑
  6. 2020
    Annual accounts 2020110,6 k €↑
  7. 2019
    Annual accounts 2019-242,2 k €
  8. 26/11/2018
    IncorporationPublic limited company